Evidence map›Paper›PMID 34250252›Full record

ArticleOpen medicine (Warsaw, Poland)2021

Travelers' vaccines and their adverse events in Nara, Japan.

Taku Ogawa, Nobuyasu Hirai, Natsuko Imakita, Hiroyuki Fujikura, Akihiro Kajita, Yuichiro Imai, Tomoko Onishi, Masahiro Takeyama, Kei Kasahara

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Taku OgawaCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Nobuyasu HiraiCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Natsuko ImakitaCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Hiroyuki FujikuraCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Akihiro KajitaCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Yuichiro ImaiCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Tomoko OnishiDepartment of Pediatrics, Nara Medical University, Nara, Japan.
Masahiro TakeyamaDepartment of Pediatrics, Nara Medical University, Nara, Japan.
Kei KasaharaCenter for Infectious Diseases, Nara Medical University, 840 Shijo-Cho Kashihara, Nara 634-8522, Japan.
Nara Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is important to analyze the types of vaccines in travel clinics to determine the focus points in future practice.

methodsWe retrospectively reviewed the electronic medical records of all patients who visited the travel clinic of Nara Medical University between June 2013 and December 2019 to determine their background and the vaccines administered. The information regarding adverse events of the unapproved vaccines in Japan (Havrix

resultsOf 645 patients, 58.6% were men and the median age was 31 years. Business was the most common travel purpose (34.9%), and Southeast Asia was the most common destination (40.2%). More than 80% of travelers to low- and middle-income countries were vaccinated against hepatitis A, while the rabies vaccination rate was approximately 50%. Typhoid vaccination coverage among travelers to South Asia was approximately 50%. The incidence of adverse events requiring medical consultation, telephonic consultation, or prolonged stay in the examination room was less than 5% for all unapproved vaccines in Japan.

conclusionMore patient education is needed to increase the vaccination rate of rabies and typhoid vaccines. Adverse events to unapproved vaccines in Japan were not high and were well-tolerated.

Indexed as

cost payerhepatitis A vaccinerabies vaccinetyphoid vaccineunapproved vaccine

Identifiers

PMID34250252
PMCPMC8247788
OpenAlexW3173882961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.